Cargando…

A 12-Month Single Arm Pilot Study to Evaluate the Efficacy and Safety of Sirolimus in Combination with Tacrolimus in Kidney Transplant Recipients at High Immunologic Risk

The optimal immunosuppressive strategy for renal transplant recipients at high immunologic risk remains a topic of investigation. This prospective single arm pilot study was undertaken to evaluate the safety and efficacy of a combined tacrolimus and sirolimus regimen in recipients at immunological h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Juhan, Lee, Jung Jun, Kim, Beom Seok, Lee, Jae Geun, Huh, Kyu Ha, Park, Yongjung, Kim, Yu Seun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444465/ https://www.ncbi.nlm.nih.gov/pubmed/26028917 http://dx.doi.org/10.3346/jkms.2015.30.6.682

Ejemplares similares

Clinical significance of tacrolimus intra-patient variability on kidney transplant outcomes according to pre-transplant immunological risk
por: Kim, Eun Jin, et al.
Publicado: (2021)

The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation
por: Lee, Juhan, et al.
Publicado: (2015)

Safety and Efficacy of Conversion from Twice-Daily Tacrolimus to Once-Daily Tacrolimus One Month after Transplantation: Randomized Controlled Trial in Adult Renal Transplantation
por: Oh, Chang-Kwon, et al.
Publicado: (2014)

Sirolimus Conversion Efficacy for Graft Function Improvement and Histopathology in Renal Recipients with Mild to Moderate Renal Insufficiency
por: Joo, Dong Jin, et al.
Publicado: (2014)

Effects of rituximab dose on hepatitis B reactivation in patients with resolved infection undergoing immunologic incompatible kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2018)

Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: a retrospective study
por: Kim, Deok Gie, et al.
Publicado: (2019)

Immunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapy
por: Khanna, Ashwani, et al.
Publicado: (2002)

Rituximab protects against development of atherosclerotic cardiovascular disease after kidney transplantation: a propensity-matched study
por: Kim, Deok Gie, et al.
Publicado: (2019)

Clinical impact of serum bilirubin levels on kidney transplant outcomes
por: Lee, Juhan, et al.
Publicado: (2021)

Early hospital readmissions after ABO- or HLA- incompatible living donor kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2019)

Safety of Tacrolimus Monotherapy within 12 Months after Liver Transplantation in the Era of Reduced Tacrolimus and Mycophenolate Mofetil: National Registry Study
por: Kim, Deok Gie, et al.
Publicado: (2022)

Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients
por: Lee, Su Hwan, et al.
Publicado: (2017)

Cellular and molecular immune profiles in renal transplant recipients after conversion from Tacrolimus to Sirolimus
por: Gallon, Lorenzo, et al.
Publicado: (2014)

Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
por: Tedesco-Silva, Helio, et al.
Publicado: (2016)

Safety and immunologic benefits of conversion to sirolimus in kidney transplant recipients with long-term exposure to calcineurin inhibitors
por: Yu, Ji Hyun, et al.
Publicado: (2016)

Systemic Immunomodulatory Effects of Combinatorial Treatment of Thalidomide and Dexamethasone on T Cells and Other Immune Cells
por: Kim, Eun Jee, et al.
Publicado: (2021)

Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants
por: Han, Seung Seok, et al.
Publicado: (2012)

Effects of metformin on hyperglycemia in an experimental model of tacrolimus- and sirolimus-induced diabetic rats
por: Jin, Jian, et al.
Publicado: (2017)

The recovery status from delayed graft function can predict long-term outcome after deceased donor kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2017)

Comparison of high-dose IVIG and rituximab versus rituximab as a preemptive therapy for de novo donor-specific antibodies in kidney transplant patients
por: Kim, Hyung Woo, et al.
Publicado: (2023)

Clinical association between tacrolimus intra-patient variability and liver transplantation outcomes in patients with and without hepatocellular carcinoma
por: Kim, Hyun Jeong, et al.
Publicado: (2022)

CYP3A5 and ABCB1 genotype influence tacrolimus and sirolimus pharmacokinetics in renal transplant recipients
por: Li, Yi, et al.
Publicado: (2015)

Long-term compensation of renal function after donor nephrectomy
por: Lee, Yong Pyo, et al.
Publicado: (2020)

The feasibility of organ transplantation during the COVID-19 outbreak: experiences from South Korea
por: Lee, Juhan, et al.
Publicado: (2020)

Comparison of humoral immunogenicity in solid organ transplant recipients after third-dose mRNA vaccine with homologous or heterologous schedules: An observational study
por: Kang, Ji-Man, et al.
Publicado: (2023)

Variability of the Estimated Glomerular Filtration Rate in the First Year after Kidney Transplantation Is an Independent Risk Factor for Poor Renal Allograft Outcomes: A Retrospective Cohort Study
por: Choi, Hoon Young, et al.
Publicado: (2016)

Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function
por: Han, Seung Seok, et al.
Publicado: (2016)

Prospective Controlled Protocol for Three Months Steroid Withdrawal with Tacrolimus, Basiliximab, and Mycophenolate Mofetil in Renal Transplant Recipients
por: Oh, Chang-Kwon, et al.
Publicado: (2012)

Reduced Prevalence of Dementia in Patients Prescribed Tacrolimus, Sirolimus, or Cyclosporine
por: Silva, Jacqueline D., et al.
Publicado: (2023)

Successful kidney transplantation across a positive complement-dependent cytotoxicity crossmatch by using C1q assay-directed, bortezomib-assisted desensitization: A case report
por: Lee, Juhan, et al.
Publicado: (2017)

Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients
por: Son, Seung Yeon, et al.
Publicado: (2017)

Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature
por: Wagle Shukla, Aparna, et al.
Publicado: (2023)

Kidney transplantation trends in South Korea during the COVID-19 pandemic
por: Lee, Juhan, et al.
Publicado: (2020)

Graft-versus-host disease after simultaneous pancreas-kidney transplantation
por: Lee, Juhan, et al.
Publicado: (2020)

Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
por: Sahman, Majda, et al.
Publicado: (2021)

Flat Pattern Peaks of Tacrolimus Absorption and Associated Pharmacogenomic Variants in Kidney Transplantation Recipients
por: Kim, Suh Min, et al.
Publicado: (2022)

Epidermal Cysts in a Tacrolimus Treated Renal Transplant Recipient
por: Ahn, In Su, et al.
Publicado: (2011)

Autophagy in kidney transplants of sirolimus treated recipients
por: Bhayana, Sagar, et al.
Publicado: (2017)

Sirolimus in renal transplant recipients with malignancies in Germany
por: Naik, Marcel G, et al.
Publicado: (2020)

Immunological Monitoring of Renal Transplant Recipients to Predict Acute Allograft Rejection Following the Discontinuation of Tacrolimus
por: Kreijveld, Ellen, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_bhe628d8uuvlf7tib5jf41oab0